findmyKOL

Robert Rollings, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionBlairsville, GA · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Rollings is a Cardiology physician. OpenAlex indexes 14 publications with 270 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

270citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

191 Deep South Farm Rd
Blairsville, GA 305122220

Telephone

706-439-6380

Provider last certified this registry record 18 Dec 2024.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.4%
    Beta blocker19.9%
    Metoprolol Succinate46%Metoprolol Tartrate26%Carvedilol18%Sotalol3%Bisoprolol Fumarate3%Nebivolol Hcl2%Atenolol2%
    Part D<11 patients
    Statin11%
    Atorvastatin Calcium55%Rosuvastatin Calcium39%Pravastatin Sodium6%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    19.1%
    Factor Xa inhibitor13.5%
    Eliquis83%Xarelto18%
    Part D76 patients
    P2Y12 inhibitor4.8%
    Clopidogrel100%
    Part D36 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.4%
    Potassium supplement2.2%
    Potassium Chloride100%
    Part D17 patients
    SGLT2 inhibitor0.8%
    Jardiance100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)8.4% facility · 91.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”